Find Research Outputs

Search concepts
Selected filters

Publication Year

  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012

Author

  • ario takeuchi
2016
1 Citation (Scopus)

Prognostic Significance of Preoperative Urine Cytology in Low-grade Non-muscle-invasive Bladder Cancer

Kiyoshima, K., Akitake, M., Shiota, M., Takeuchi, A., Takahashi, R., Inokuchi, J., Tatsugami, K., Yokomizo, A. & Eto, M., Feb 1 2016, In : Anticancer research. 36, 2, p. 799-802 4 p.

Research output: Contribution to journalArticle

5 Citations (Scopus)
2017

Differential risk of castration resistance after initial radical prostatectomy or radiotherapy for prostate cancer

Obata, H., Shiota, M., Akitake, N., Takeuchi, A., Kashiwagi, E., Dejima, T., Kiyoshima, K., Inokuchi, J., Tatsugami, K. & Eto, M., Oct 2017, In : Anticancer research. 37, 10, p. 5631-5637 7 p.

Research output: Contribution to journalArticle

2019
2016

External validation of preoperative nomograms predicting lymph node involvement in patients who underwent extended pelvic lymph node dissection during robot-assisted radical prostatectomy

Inokuchi, J., Namitome, R., Kiyoshima, K., Takeuchi, A., Shiota, M., Takahashi, R., Tatsugami, K., Yokomizo, A. & Eto, M., Sep 2016, In : Nishinihon Journal of Urology. 78, 9, p. 451-456 6 p.

Research output: Contribution to journalArticle

2013

Elucidating the mechanism behind prostate cancer progression resulting from oxidative stress and its application to the clinical setting

Shiota, M., Yokomizo, A., Song, Y., Takeuchi, A., Kuroiwa, K. & Naito, S., Apr 1 2013, In : Nishinihon Journal of Urology. 75, 4, p. 164-169 6 p.

Research output: Contribution to journalArticle

2015

Inhibition of the HER2-YB1-AR axis with lapatinib synergistically enhances enzalutamide anti-tumor efficacy in castration resistant prostate cancer

Shiota, M., Bishop, J. L., Takeuchi, A., Nip, K. M., Cordonnier, T., Beraldi, E., Kuruma, H., Gleave, M. E. & Zoubeidi, A., Jan 1 2015, In : Oncotarget. 6, 11, p. 9086-9098 13 p.

Research output: Contribution to journalArticle

22 Citations (Scopus)
2017
6 Citations (Scopus)
2019

Overview of current and future systemic therapy for metastatic renal cell carcinoma

Osawa, T., Takeuchi, A., Kojima, T., Shinohara, N., Eto, M. & Nishiyama, H., Jan 1 2019, In : Japanese journal of clinical oncology. 49, 5, p. 395-403 9 p.

Research output: Contribution to journalArticle

3 Citations (Scopus)
2 Citations (Scopus)
2012

Sunitinib enhances antitumor effects against chemotherapy-resistant bladder cancer through suppression of ERK1/2 phosphorylation

Takeuchi, A., Eto, M., Shiota, M., Tatsugami, K., Yokomizo, A., Kuroiwa, K., Itsumi, M. & Naito, S., May 1 2012, In : International journal of oncology. 40, 5, p. 1691-1696 6 p.

Research output: Contribution to journalArticle

16 Citations (Scopus)
2019

The impact of genetic polymorphism on CYP19A1 in androgen-deprivation therapy among Japanese men

Shiota, M., Fujimoto, N., Tsukahara, S., Ushijima, M., Takeuchi, A., Kashiwagi, E., Inokuchi, J., Tatsugami, K., Uchiumi, T. & Eto, M., Jan 1 2019, In : Cancer chemotherapy and pharmacology.

Research output: Contribution to journalArticle

1 Citation (Scopus)
2016

The prognostic impact of serum testosterone during androgen-deprivation therapy in patients with metastatic prostate cancer and the SRD5A2 polymorphism

Shiota, M., Fujimoto, N., Yokomizo, A., Takeuchi, A., Kashiwagi, E., Dejima, T., Kiyoshima, K., Inokuchi, J., Tatsugami, K. & Eto, M., Jun 1 2016, In : Prostate Cancer and Prostatic Diseases. 19, 2, p. 191-196 6 p.

Research output: Contribution to journalArticle

15 Citations (Scopus)
2018

Neoadjuvant androgen-deprivation therapy with radical prostatectomy for prostate cancer in association with age and serum testosterone

Akitake, N., Shiota, M., Obata, H., Takeuchi, A., Kashiwagi, E., Imada, K., Kiyoshima, K., Inokuchi, J., Tatsugami, K. & Eto, M., Sep 2018, In : Prostate International. 6, 3, p. 104-109 6 p.

Research output: Contribution to journalArticle

1 Citation (Scopus)

SEMA3C drives cancer growth by transactivating multiple receptor tyrosine kinases via Plexin B1

Peacock, J. W., Takeuchi, A., Hayashi, N., Liu, L., Tam, K. J., Al Nakouzi, N., Khazamipour, N., Tombe, T., Dejima, T., Lee, K. C. K., Shiota, M., Thaper, D., Lee, W. C. W., Hui, D. H. F., Kuruma, H., Ivanova, L., Yenki, P., Jiao, I. Z. F., Khosravi, S., Mui, A. L. F. & 5 others, Fazli, L., Zoubeidi, A., Daugaard, M., Gleave, M. E. & Ong, C. J., Feb 1 2018, In : EMBO Molecular Medicine. 10, 2, p. 219-238 20 p.

Research output: Contribution to journalArticle

12 Citations (Scopus)
7 Citations (Scopus)
2014

Targeting ribosomal S6 kinases/Y-box binding protein-1 signaling improves cellular sensitivity to taxane in prostate cancer

Shiota, M., Itsumi, M., Yokomizo, A., Takeuchi, A., Imada, K., Kashiwagi, E., Inokuchi, J., Tatsugami, K., Uchiumi, T. & Naito, S., Jun 2014, In : Prostate. 74, 8, p. 829-838 10 p.

Research output: Contribution to journalArticle

15 Citations (Scopus)
2018

Detection of identical T cell clones in peritumoral pleural effusion and pneumonitis lesions in a cancer patient during immune-checkpoint blockade

Tanaka, K., Yanagihara, T., Ikematsu, Y., Inoue, H., Ota, K., Kashiwagi, E., Suzuki, K., Hamada, N., Takeuchi, A., Tatsugami, K., Eto, M., Ijichi, K., Oda, Y., Otsubo, K., Yoneshima, Y., Iwama, E., Nakanishi, Y. & Okamoto, I., Jul 17 2018, In : Oncotarget. 9, 55, p. 30587-30593 7 p.

Research output: Contribution to journalArticle

8 Citations (Scopus)

Collateral resistance to taxanes in enzalutamide-resistant prostate cancer through aberrant androgen receptor and its variants

Shiota, M., Dejima, T., Yamamoto, Y., Takeuchi, A., Imada, K., Kashiwagi, E., Inokuchi, J., Tatsugami, K., Kajioka, S., Uchiumi, T. & Eto, M., Oct 2018, In : Cancer Science. 109, 10, p. 3224-3234 11 p.

Research output: Contribution to journalArticle

5 Citations (Scopus)
2017

Smoking effect on oncological outcome among men with prostate cancer after radical prostatectomy

Sato, N., Shiota, M., Shiga, K. I., Takeuchi, A., Inokuchi, J., Tatsugami, K., Yokomizo, A., Koga, H., Yamaguchi, A., Naito, S. & Eto, M., May 1 2017, In : Japanese journal of clinical oncology. 47, 5, p. 453-457 5 p., hyx013.

Research output: Contribution to journalArticle

3 Citations (Scopus)
2014

Insulin-like growth factor-I induces CLU expression through Twist1 to promote prostate cancer growth

Takeuchi, A., Shiota, M., Beraldi, E., Thaper, D., Takahara, K., Ibuki, N., Pollak, M., Cox, M. E., Naito, S., Gleave, M. E. & Zoubeidi, A., Mar 25 2014, In : Molecular and Cellular Endocrinology. 384, 1-2, p. 117-125 9 p.

Research output: Contribution to journalArticle

8 Citations (Scopus)
2016

Co-introduction of a steroid with docetaxel chemotherapy for metastatic castration-resistant prostate cancer affects PSA flare

Shiota, M., Yokomizo, A., Takeuchi, A., Kiyoshima, K., Inokuchi, J., Tatsugami, K., Shiga, K. I., Koga, H., Yamaguchi, A., Naito, S. & Eto, M., Dec 1 2016, In : BJU international. 118, 6, p. 880-884 5 p.

Research output: Contribution to journalArticle

4 Citations (Scopus)
2012
9 Citations (Scopus)
2013

A C-type lectin receptor pathway is responsible for the pathogenesis of acute cyclophosphamide-induced cystitis in mice

Dejima, T., Shibata, K., Yamada, H., Takeuchi, A., Hara, H., Eto, M., Naito, S. & Yoshikai, Y., Dec 1 2013, In : MICROBIOLOGY and IMMUNOLOGY. 57, 12, p. 833-841 9 p.

Research output: Contribution to journalArticle

1 Citation (Scopus)
2012

Androgen receptor signaling regulates cell growth and vulnerability to doxorubicin in bladder cancer

Shiota, M., Takeuchi, A., Yokomizo, A., Kashiwagi, E., Tatsugami, K., Kuroiwa, K. & Naito, S., Jul 1 2012, In : Journal of Urology. 188, 1, p. 276-286 11 p.

Research output: Contribution to journalArticle

40 Citations (Scopus)
2020
Open Access
2014

The feature of metabolic syndrome is a risk factor for biochemical recurrence after radical prostatectomy

Shiota, M., Yokomizo, A., Takeuchi, A., Imada, K., Kiyoshima, K., Inokuchi, J., Tatsugami, K. & Naito, S., Sep 2014, In : Journal of Surgical Oncology. 110, 4, p. 476-481 6 p.

Research output: Contribution to journalArticle

27 Citations (Scopus)
2019
Open Access
2017

Suppressed Recurrent Bladder Cancer after Androgen Suppression with Androgen Deprivation Therapy or 5α-Reductase Inhibitor

Shiota, M., Kiyoshima, K., Yokomizo, A., Takeuchi, A., Kashiwagi, E., Dejima, T., Takahashi, R., Inokuchi, J., Tatsugami, K. & Eto, M., Feb 1 2017, In : Journal of Urology. 197, 2, p. 308-313 6 p.

Research output: Contribution to journalArticle

17 Citations (Scopus)
2012

Clusterin mediates TGF-β-induced epithelial-mesenchymal transition and metastasis via Twist1 in prostate cancer cells

Shiota, M., Zardan, A., Takeuchi, A., Kumano, M., Beraldi, E., Naito, S., Zoubeidi, A. & Gleave, M. E., Oct 15 2012, In : Cancer Research. 72, 20, p. 5261-5272 12 p.

Research output: Contribution to journalArticle

96 Citations (Scopus)
2017

Tumor-infiltrating lymphocyte-mediated pleuritis followed by marked shrinkage of metastatic kidney cancer of the chest wall during nivolumab treatment

Yanagihara, T., Tanaka, K., Ota, K., Kashiwagi, E., Takeuchi, A., Tatsugami, K., Eto, M., Nakanishi, Y. & Okamoto, I., Aug 1 2017, In : Annals of Oncology. 28, 8, p. 2038-2039 2 p., mdx214.

Research output: Contribution to journalLetter

5 Citations (Scopus)
2018

Mineralocorticoid receptor signaling affects therapeutic effect of enzalutamide

Shiota, M., Fujimoto, N., Higashijima, K., Imada, K., Kashiwagi, E., Takeuchi, A., Inokuchi, J., Tatsugami, K., Kajioka, S., Uchiumi, T. & Eto, M., Oct 1 2018, In : Prostate. 78, 14, p. 1045-1052 8 p.

Research output: Contribution to journalArticle

4 Citations (Scopus)
2017

Gene polymorphisms in antioxidant enzymes correlate with the efficacy of androgen-deprivation therapy for prostate cancer with implications of oxidative stress

Shiota, M., Fujimoto, N., Itsumi, M., Takeuchi, A., Inokuchi, J., Tatsugami, K., Yokomizo, A., Kajioka, S., Uchiumi, T. & Eto, M., Jan 1 2017, In : Annals of Oncology. 28, 3, p. 569-575 7 p.

Research output: Contribution to journalArticle

13 Citations (Scopus)

Protein kinase C regulates Twist1 expression via NF-κB in prostate cancer

Shiota, M., Yokomizo, A., Takeuchi, A., Kashiwagi, E., Dejima, T., Inokuchi, J., Tatsugami, K., Uchiumi, T. & Eto, M., Apr 2017, In : Endocrine-Related Cancer. 24, 4, p. 171-180 10 p.

Research output: Contribution to journalArticle

5 Citations (Scopus)
2018
2 Citations (Scopus)
2019
2018
Open Access
1 Citation (Scopus)
2012

Antioxidant therapy alleviates oxidative stress by androgen deprivation and prevents conversion from androgen dependent to castration resistant prostate cancer

Shiota, M., Song, Y., Takeuchi, A., Yokomizo, A., Kashiwagi, E., Kuroiwa, K., Tatsugami, K., Uchiumi, T., Oda, Y. & Naito, S., Feb 1 2012, In : Journal of Urology. 187, 2, p. 707-714 8 p.

Research output: Contribution to journalArticle

35 Citations (Scopus)
2013

Interaction between docetaxel resistance and castration resistance in prostate cancer: Implications of Twist1, YB-1, and androgen receptor

Shiota, M., Kashiwagi, E., Yokomizo, A., Takeuchi, A., Dejima, T., Song, Y., Tatsugami, K., Inokuchi, J., Uchiumi, T. & Naito, S., Sep 1 2013, In : Prostate. 73, 12, p. 1336-1344 9 p.

Research output: Contribution to journalArticle

38 Citations (Scopus)

Human heterochromatin protein 1 Isoforms regulate androgen receptor signaling in prostate cancer

Itsumi, M., Shiota, M., Yokomizo, A., Kashiwagi, E., Takeuchi, A., Tatsugami, K., Inokuchi, J., Song, Y., Uchiumi, T. & Naito, S., Mar 27 2013, In : Journal of Molecular Endocrinology. 50, 3, p. 401-409 9 p.

Research output: Contribution to journalArticle

10 Citations (Scopus)
2014

Risk factors for febrile neutropenia in patients receiving docetaxel chemotherapy for castration-resistant prostate cancer

Shiota, M., Yokomizo, A., Takeuchi, A., Kiyoshima, K., Inokuchi, J., Tatsugami, K. & Naito, S., Jan 1 2014, In : Supportive Care in Cancer. 22, 12, p. 3219-3226 8 p.

Research output: Contribution to journalArticle

5 Citations (Scopus)
2016

Equol inhibits prostate cancer growth through degradation of androgen receptor by S-phase kinase-associated protein 2

Itsumi, M., Shiota, M., Takeuchi, A., Kashiwagi, E., Inokuchi, J., Tatsugami, K., Kajioka, S., Uchiumi, T., Naito, S., Eto, M. & Yokomizo, A., Jul 1 2016, In : Cancer Science. 107, 7, p. 1022-1028 7 p.

Research output: Contribution to journalArticle

13 Citations (Scopus)
2015

Renal cancer treatment with recipient lymphocyte infusion enhanced the antitumor effect of nonmyeloablative allogeneic stem cell transplantation

Takeuchi, A., Eto, M., Tatsugami, K., Yamada, H., Yokomizo, A., Shiota, M., Itsumi, M., Inokuchi, J., Kiyoshima, K., Dejima, T., Imada, K., Naito, S. & Yoshikai, Y., Mar 1 2015, In : Transplant Immunology. 32, 2, p. 131-139 9 p.

Research output: Contribution to journalArticle

3 Citations (Scopus)
2014

Inhibition of protein kinase C/twist1 signaling augments anticancer effects of androgen deprivation and enzalutamide in prostate cancer

Shiota, M., Yokomizo, A., Takeuchi, A., Imada, K., Kashiwagi, E., Song, Y., Inokuchi, J., Tatsugami, K., Uchiumi, T. & Naito, S., Feb 26 2014, In : Clinical Cancer Research. 20, 4, p. 951-961 11 p.

Research output: Contribution to journalArticle

26 Citations (Scopus)
2015

Secondary bladder cancer after anticancer therapy for prostate cancer: Reduced comorbidity after androgen-deprivation therapy

Shiota, M., Yokomizo, A., Takeuchi, A., Imada, K., Kiyoshima, K., Inokuchi, J., Tatsugami, K., Ohga, S., Nakamura, K., Honda, H. & Naito, S., Jan 1 2015, In : Oncotarget. 6, 16, p. 14710-14719 10 p.

Research output: Contribution to journalArticle

22 Citations (Scopus)
2014

PMA induces androgen receptor downregulation and cellular apoptosis in prostate cancer cells

Itsumi, M., Shiota, M., Yokomizo, A., Takeuchi, A., Kashiwagi, E., Dejima, T., Inokuchi, J., Tatsugami, K., Uchiumi, T. & Naito, S., Apr 29 2014, In : Journal of Molecular Endocrinology. 53, 1, p. 31-41 11 p.

Research output: Contribution to journalArticle

9 Citations (Scopus)
2015

Prognostic Impact of Serum Testosterone and Body Mass Index Before Androgen-deprivation Therapy in Metastatic Prostate Cancer

Shiota, M., Takeuchi, A., Sugimoto, M., Kashiwagi, E., Dejima, T., Kiyoshima, K., Inokuchi, J., Tatsugami, K. & Yokomizo, A., Dec 1 2015, In : Anticancer research. 35, 12, p. 6925-6932 8 p.

Research output: Contribution to journalArticle

5 Citations (Scopus)
2019

Serum Prognostic Factors of Androgen-deprivation Therapy among Japanese Men with De Novo Metastatic Prostate Cancer

Kobayashi, T., Namitome, R., Hirata, Y., Shiota, M., Imada, K., Kashiwagi, E., Takeuchi, A., Inokuchi, J., Tatsugami, K. & Eto, M., Jan 1 2019, In : Anticancer research. 39, 6, p. 3191-3195 5 p.

Research output: Contribution to journalArticle

2015

Low serum testosterone but not obesity predicts high gleason score at biopsy diagnosed as prostate cancer in patients with serum PSA lower than 20 ng/ml

Shiota, M., Takeuchi, A., Sugimoto, M., Dejima, T., Kashiwagi, E., Kiyoshima, K., Inokuchi, J., Tatsugami, K. & Yokomizo, A., Nov 2015, In : Anticancer research. 35, 11, p. 6137-6145 9 p.

Research output: Contribution to journalArticle

3 Citations (Scopus)